Nanoflex Robotics raises 12 million US dollars

Nanoflex Robotics AG from Zurich has raised 12 million US dollars from investors. The spin-off from the Swiss Federal Institute of Technology in Zurich (ETH) intends to use this fresh capital injection in order to bring its first-generation robot system to market and accelerate the development of innovative neuro-interventional products, further details of which can be found in a press release. A first in-human trial and submission with the regulatory authority, the US Food and Drug Administration (FDA), are accordingly planned for the third quarter of 2023.

The financing round was led by Ascend Capital Partners, an international venture capital firm headquartered in Vienna in the US State of Virginia. Family offices also supported the medtech start-up in the financing round. These included the Hong Kong-based Kinled and Mountain Labs AG from Schönried in the canton of Bern.

“We are excited to support this exceptional team in reinventing the surgical robotic space with remote vascular interventions”, comments Jerry Hong, CEO of Ascend Capital Partners, in the press release. In particular, the company’s ability to facilitate faster surgery for stroke patients and, in so doing, potentially maintain the quality of life of stroke patients is worthy of recognition, Jerry Hong adds.

Nanoflex Robotics was founded in Zurich by Bradley Nelson, Christophe Chautems and Matt Curran in 2021. The company manufactures a generator for remote-controlled vascular procedures. By generating and controlling electromagnetic fields, the mobile and compact generator enables precise and flexible control of magnetically guided wires and catheters in blood vessels, even via remote access. ko